Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

AstraZeneca

Status: Completed

Conditions: Schizophrenia

Study type: Observational

Funder types: Industry

Identifiers

NCT00873249

NIS-NES-DUM-2007/3

Details and patient eligibility

About

This study is a 6-month, multicenter, randomized study to assess the effect of daily SMS reminders sent during 3 months in the adherence to oral antipsychotic treatment in stabilized outpatients with schizophrenia.

Enrollment: 339 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or female patients older than 18 years
• With a diagnosis of schizophrenia (DSM-IV TR criteria)
• Stabilized out-patients
• Under oral antipsychotic monotherapy

Exclusion criteria

• Administration of a depot antipsychotic drug
• Suicide risk